series-c-plus
Stage
2
Investors
About
MediWound is a biotechnology company developing enzymatic treatments for non-surgical tissue repair, focusing on products for burn eschar removal and chronic wound debridement with approvals and trials in multiple global markets.
Explore MediWound's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.